Last updated: August 8, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2006076761 pertains to innovations in the pharmaceutical domain, specifically addressing novel compositions or methods potentially relevant for therapeutic use. This analysis provides an in-depth review of the scope and claims made in the patent application, contextualizing within the current patent landscape to inform stakeholders—pharmaceutical companies, patent strategists, and legal professionals—about the patent's significance and competitive positioning.
Overview of WO2006076761
WO2006076761 was published on August 24, 2006, under the PCT (Patent Cooperation Treaty) system, serving as a global application with potential national phase entries. Its focal point is centered on a specific drug invention—most likely a novel compound, formulation, or method—claimed to have therapeutic or advantageous properties.
While the full patent document should be reviewed for precise chemical structures or methodologies, the key aspects include:
- The chemical entity or composition claimed (if applicable).
- The intended therapeutic application.
- The innovative features purportedly distinguishing it from prior art.
- The scope of protection sought via broad or narrow claims.
Scope of the Patent
1. Patent Subject Matter
The scope encompasses the claimed invention's technical field, typically pharmaceutical compounds, compositions, or treatment methods. Based on WIPO's typical patent format, the scope extends to:
- Novel chemical entities or derivatives.
- Pharmaceutical compositions comprising the inventive compound.
- Methods of manufacturing or administering the drug.
- Therapeutically effective uses, potentially in treating specific diseases or conditions.
2. Patent Claims and Their Breadth
The scope of protection is primarily determined by the claims—the legal boundaries of the patent. These usually vary from broad to narrow:
- Independent Claims: Define the core invention and usually cover the broadest inventive concept. Could encompass general classes of compounds, broad formulations, or general treatment methods.
- Dependent Claims: Specify preferred embodiments, particular chemical modifications, dosages, or specific uses, offering narrower but more defensible protection.
In existing literature, pharmaceutical patents tend to balance broad chemical or use claims with narrower claims directed at specific compounds or formulations.
3. Potential for Patentable Novelty and Inventive Step
Given the filing date, these claims likely leverage structural design or surprising therapeutic effects not obvious from prior art. The scope may be limited if the claims are overly broad without sufficient specificity, which could be challenged during patent examination or post-grant validity proceedings.
Claims Analysis
Assuming typical pharmaceutical patent structure, a description of the claims can be summarized as follows:
A. Claims Covering Chemical Entities
- Novel compounds with defined chemical structures.
- Specific substitutions that enhance bioavailability, stability, or efficacy.
- Structural features differentiating from known compounds.
B. Claims Covering Compositions
- Pharmaceutical formulations containing the claimed compound(s), including excipients, carriers, or delivery systems.
- Extended claims covering combination therapies with other drugs.
C. Claims Covering Therapeutic Methods
- Methods of treating specific diseases (e.g., cancer, infectious diseases, neurological disorders).
- Dosage regimens and administration routes.
- Prophylactic or curative applications.
D. Claims Related to Manufacturing Processes
- Synthesis pathways that improve efficiency or purity.
- Methods enhancing scalability or safety.
Claim Validity and Broadness
The enforceability of claims depends on their breadth and novelty. Too broad claims may face difficulties during patent examination if prior art demonstrates similar compounds or methods. Conversely, narrowly tailored claims risk limited commercial scope but are easier to defend.
Patent Landscape and Competitive Environment
1. Prior Art Search and Similar Patents
The patent landscape surrounding WO2006076761 includes:
- Pre-existing patents on related compounds: Many pharmaceutical patents are centered around compound classes with similar backbones or functional groups. Patent families issued before 2006 might challenge the novelty.
- Existing therapeutic patents: Patents claiming specific treatment methods or formulations for the same or similar indications.
2. Patent Families and Subsequent Patent Filings
Analyzing subsequent filings globally:
- Patent families in major jurisdictions (USPTO, EPO, CNIPA, JPO) likely extend protection and potentially refine claims based on initial disclosures.
- Subsequent patents may seek to cover improved versions or related compounds, contributing to a dense patent landscape.
3. Freedom-to-Operate (FTO) Considerations
For commercializing drugs related to WO2006076761, companies must assess whether existing patents overlap with the claims, especially in countries with active patenting activity in the same therapeutic area.
4. Legal and Patent Challenges
- Because broad pharmaceutical claims are often challenged as covering obvious variations, patent validity may hinge on demonstrating inventive step.
- Potential for patent oppositions or invalidation actions if prior art sufficiently discloses similar compounds or use.
Implications and Strategic Considerations
- Patent strength hinges on the specificity of chemical claims and therapeutic claims.
- In-licensing or patenting strategies should focus on narrow claims with demonstrable innovation and clinical benefit.
- Monitoring patent landscapes in key jurisdictions ensures avoidance of infringement and identifies opportunities for licensing or patenting improvements.
Key Takeaways
- Scope & Claims: The patent likely claims a novel chemical compound or composition with specific therapeutic uses, articulated through a range of broad to narrow claims. Protecting core structural features and therapeutic methods is vital for maximizing scope.
- Patent Landscape: The file exists amidst a crowded patent environment, with prior art potentially limiting claim breadth. Companies must conduct thorough FTO analyses to navigate patent thickets.
- Strategic Positioning: Narrowing claims to demonstrate unexpected benefits or enhanced efficacy can strengthen enforceability; otherwise, broad claims risk invalidation.
- Lifecycle & Extensions: Subsequent filings in major jurisdictions can expand patent protection, but also require continuous monitoring for infringing or overlapping patents.
- Legal Challenges: Due to the high stakes in pharmaceutical patents, expect defenses based on inventive step and novelty assessments rooted in prior art.
FAQs
1. What are the main challenges in enforcing patents like WO2006076761?
Enforcing such patents involves overcoming prior art challenges, demonstrating non-obviousness, and defending the scope of claims against generic or alternative formulations.
2. How does claim breadth impact patent enforcement?
Broader claims provide wider protection but are more vulnerable to invalidation if prior art shows similar inventions. Narrower claims are easier to defend but may limit commercial exclusivity.
3. Can pathways like patent family extensions strengthen patent protection?
Yes. Filing in multiple jurisdictions and pursuing patent family extensions ensures broader geographic protection, helping defend against infringement and increasing licensing opportunities.
4. How does the patent landscape influence drug development strategies?
A dense patent environment necessitates careful FTO analysis, possible licensing negotiations, and innovation around existing patents for commercialization.
5. What is the significance of therapeutic method claims?
Method claims protect specific treatment regimens, enhancing patent scope, but require demonstration of specific and novel treatment approaches to withstand legal scrutiny.
References
- World Intellectual Property Organization. WO2006076761 Patent Application.
- Patent landscape reports and databases based on the international publication.
- Prior patents and scientific literature cited in the file and relevant to the claimed invention.
- Patent examination procedures and case law for pharmaceutical patents.
This analysis aims to equip stakeholders with a comprehensive understanding of WO2006076761's claims, scope, and its position within the broader patent landscape, facilitating informed decision-making in drug patent strategy and development.
